Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Granitzer Janine |
** = Publikationen gelistet in SCI/SSCI/Pubmed
2024
Abstract (Zeitschrift)
** Seeber, A; Huemer, F; Doleschal, B; Taghizadeh, H; Reimann, P; Moik, F; Kostmann, S; Wagner, L; Granitzer, J; Hamid, MA; Bachleitner, C; Amann, A; Wolf, D; Greil, R; Jost, PJ; Winder, T; Rumpold, H; Weiss, L; Gerger, A; Riedl, JM
Real-world effectiveness and predictive biomarker analysis of TAS-102+bevacizumab vs. regorafenib vs. TAS-102 in metastatic colorectal cancer: A multicenter cohort study
ANN ONCOL. 2024; 35: S445-S446.
Doi: 10.1016/j.annonc.2024.08.599
Web of Science
FullText
FullText_MUG
2023
Originalarbeit (Zeitschrift)
** Doleschal, B; Taghizadeh, H; Lentner, T; Riedl, JM; Granitzer, J; Morariu, D; Decker, J; Aichberger, KJ; Webersinke, G; Kirchweger, P; Petzer, A; Rumpold, H
Bevacizumab mitigates codon-specific effects of trifluridine/tipiracil on efficacy outcome parameters in metastatic colorectal cancer.
ESMO Open. 2023; 8(6):102064
Doi: 10.1016/j.esmoop.2023.102064
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG